RecruitingNCT06067295

Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

Sponsor

University of Southern California

Enrollment

300 participants

Start Date

Feb 21, 2023

Study Type

OBSERVATIONAL

Conditions

Prostate Carcinoma

Summary

This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.

Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study (LAPCC) is a longitudinal registry — it follows men with advanced (metastatic) prostate cancer over time to understand how the disease progresses, how different treatments affect outcomes, and what factors influence quality of life. **You may be eligible if...** - You are a man aged 18 or older, of any racial or ethnic background - You have been diagnosed with metastatic (advanced/spread) prostate cancer - You are about to start a new systemic treatment (any line of therapy) - Prior participation in clinical trials is allowed **You may NOT be eligible if...** - You are unable to provide informed consent - You have had another cancer within the past 3 years (unless previously cured) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.